Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis

November 2019
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
Simón Serrano. S, Grönberg. A, Longato. L, Rombouts. K, Kuo. J, Gregory. M, Moss. S, Elmér. E, Mazza. G, Gallay. P, Pinzani. M, Hansson. M.J, Massoumi. R.
Cells. 8(11):1409.